Robotic Right Hemicolectomy Versus Laparoscopic Right Hemicolectomy (PRORHEM)
Colorectal Neoplasms, Colorectal Neoplasms Malignant, Colorectal Neoplasms, Benign
About this trial
This is an interventional treatment trial for Colorectal Neoplasms
Eligibility Criteria
Inclusion Criteria: Adult patients requiring elective minimally invasive RHC for polyps not amenable to endoscopic resection or for cTis-T3 Nx M0 cancer of the right colon (including cancer of the appendix, caecum, ascending colon and hepatic flexure). Exclusion Criteria: Not scheduled for minimally invasive RHC (refuses surgery and/or planned open approach) Emergency surgery Hereditary colorectal cancer Inflammatory bowel disease Synchronous resection of (an)other organ(s) Synchronous surgical procedure (including more extended resection of the lower gastrointestinal tract) cT4 cM+ History of laparotomy Pregnancy No anastomosis planned Unable to provide informed consent No informed consent
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Robotic right hemicolectomy
Laparoscopic right hemicolectomy
Robotic right hemicolectomy with intracorporeal anastomosis and extraction through a C-section (fully minimally invasive right hemicolectomy)
Laparoscopic right hemicolectomy with extracorporeal anastomosis and extraction through midline (standard of care)